SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Make a comment > Terms and Conditions

  1. When posting or reading you agree:
    1. To accept full responsibility for the views you contribute.
    2. To use this function only for lawful purposes.
    3. Not to post defamatory, abusive, offensive, racist, sexist, threatening, vulgar, obscene, hateful or otherwise inappropriate comments, or to post comments which will constitute a criminal offence or give rise to civil liability.
    4. Not to post or make available any material which is protected by copyright, trade mark or other proprietary right without the express permission of the owner of the copyright, trade mark or any other proprietary right.
    5. Not to post any content that is advertising related.
    6. To evaluate for yourself the accuracy of any opinion, advice or other content.
    7. To supply your name and e mail address.
  2. Complaints
    1. You wish to complain about any content please use the "Report Abuse" feature and include details of your complaint, what action you would like us to take and how we can contact you.
  3. Monitoring
    1. Contributions to Make A Comment will be moderated before being published. If our attention is drawn to allegedly inappropriate content we reserve the right remove the material or the comment.
    2. Comments displaying advertising material will not be published.
    3. We reserve the right not to publish comments. Correspondence with contributors over comments which have been declined for publication will not be entertained.
  4. General
    1. We reserve the right to reveal your identity and contact details to third parties if we believe that you may have breached any of our terms and conditions.
    2. By posting material on Make a Comment, you grant all other users the right to obtain access to this material.
    3. You acknowledge that the author of each contribution is responsible for his or her comments.
    4. We are not responsible for the accuracy, veracity or reliability of any opinion, advice or statement made on Make A Comment unless it is edited by us. If un-modified by us, contributions shall not be considered to be reviewed, edited or approved by William Reed Business Media.
    5. Readers are asked to keep their comments concise and relevant to the topic in question.

Spotlight

Distributing donated drugs a major challenge says UK neglected diseases group

Distributing donated drugs a major challenge says UK neglected diseases group

More drugs for tropical diseases have been donated since the London declaration of 2012, but getting them...

Novasep to make API for Celladon's heart attack gene therapy
update

Novasep joins Lonza as Mydicar API producer in deal with Celladon

Novasep and Lonza will both make the API for Celladon's heart attack therapy, Mydicar.

Lethal injection drug shortage brings return of firing squad in Utah

Lethal injection drug shortage brings return of firing squad in Utah

Utah will allow execution by firing squad as European pharmaceutical companies refuse to provide drugs for lethal...

Growing elderly population to drive drug excipients sector, study

Growth with aid of Grey: Elderly folks to drive excipients sector, study

Demand for pensioner friendly pills will be an important growth driver for the drug excipients sector according...

WHO calls for proactive strategies to combat falsified, substandard medicines

WHO calls for proactive strategies to combat falsified, substandard medicines

The WHO’s latest report on substandard/spurious/falsely-labelled/falsified/counterfeit (SSFFC) medical products has the organization divvying up certain responsibilities for...

US diabetics pay most for drugs, but world’s poorest bear the biggest economic burden

US diabetics pay most for drugs, but world’s poorest bear the biggest economic burden

Further evidence US diabetics pay more for drugs than sufferers in comparable countries has emerged this month...